Senetek PLC Announces Debut Of Pyratine-6(TM) At The Annual Meeting Of The American Academy Of Dermatology

Main Category: Dermatology
Also Included In: Seniors / Aging;  Conferences
Article Date: 06 Feb 2008 - 0:00 PDT

email to a friend   printer friendly   opinions  

Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the development of technologies that target the science of healthy aging, announced the debut of Pyratine-6(TM) at the 66th Annual Meeting of the American Academy of Dermatology in San Antonio, Texas.

Pyratine-6(TM), Senetek's exclusive second generation cytokinin, has been clinically proven to be effective in correcting visible signs of skin aging and significantly reducing erythema as early as two weeks from onset of use.

The Annual Meeting of the American Academy of Dermatology runs from February 1 - 5, 2008. Approximately 7,000 medical personnel are registered to attend.

Commenting on the debut, Mr. Frank Massino, Senetek's Chairman and Chief Executive Officer stated, "We are delighted to see this compelling therapeutic come to the market and are very pleased by the reception Pyratine-6(TM) has received from dermatologists at this important conference. Pyratine-6(TM) has been successfully clinically tested and has shown attributes more beneficial to treatment than any predecessor compound."

About Senetek PLC

Senetek PLC (OTC Bulletin Board: SNKTY) is a Life Sciences company engaged in the development of breakthrough technologies that target the science of healthy aging. The Company's extensive research collaborations have resulted in a strong pipeline of patented compounds and products with broad therapeutic applications and a leading presence in dermatology. Senetek collaborates with established specialty pharmaceutical companies in the final development and marketing of its proprietary products, most recently resulting in the development of the best-selling anti-aging product sold in the North American physician market.

For more information, visit the company's website at http://www.senetekplc.com.

This news release contains statements that may be considered 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act. Forward-looking statements by their nature involve substantial uncertainty, and actual results may differ materially from those that might be suggested by such statements. Important factors identified by the Company that it believes could result in such material differences are described in the Company's Annual Report on Form 10-K for the year 2006. However, the Company necessarily can give no assurance that it has identified or will identify all of the factors that may result in any particular forward-looking statement materially differing from actual results, and the Company assumes no obligation to correct or update any forward-looking statements which may prove to be inaccurate, whether as a result of new information, future events or otherwise.

Senetek PLC
http://www.senetekplc.com

• Additional
• References
• Citations